Eur Rev Med Pharmacol Sci 2023; 27 (17): 8190-8197
DOI: 10.26355/eurrev_202309_33579

Mindfulness-based stress reduction in cancer patients: impact on overall survival, quality of life and risk factor

P. Forte, V. Abate, I. Bolognini, O. Mazzoni, V. Quagliariello, N. Maurea, D. Di Bonito, E. Quarata, G. Migliaccio, M. Petrillo, D. Barberio

Oncologic Psychology, Istituto Nazionale Tumori – IRCCS-Fondazione G. Pascale, Naples, Italy. fortepietro19@gmail.com


Mindfulness-based stress reduction, a complementary and alternative therapy, is able to decrease cancer-related fatigue, and stress and to improve the quality of life in cancer patients. Some studies evaluated if mindfulness-based stress reduction could improve some cardiometabolic and cancer risk factors, including systemic chemokines, growth factors, and pro-inflammatory biomarkers (e.g., C-reactive protein, Interleukin-1). In this narrative review, we highlight the pleiotropic beneficial effects of mindfulness-based stress reduction and its clinical impact on cardiovascular and cancer risk factors among patients with cancer in different stages. Moreover, improvements in the overall quality of life, sleep quality, and immune functions [changes in plasma levels of interleukin-4 (IL-4), interferon-γ (INF-γ), and interleukin-10 (IL-10)] will also be discussed. Albeit few clinical studies available in the literature, evidenced the beneficial effects of mindfulness-based stress reduction on the immune and cardiometabolic profile in cancer patients, providing important insights into the closest collaboration between psycho-oncologists, oncologists, and cardiologists.

Free PDF Download

To cite this article

P. Forte, V. Abate, I. Bolognini, O. Mazzoni, V. Quagliariello, N. Maurea, D. Di Bonito, E. Quarata, G. Migliaccio, M. Petrillo, D. Barberio
Mindfulness-based stress reduction in cancer patients: impact on overall survival, quality of life and risk factor

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 17
Pages: 8190-8197
DOI: 10.26355/eurrev_202309_33579